jan123
Generic: Low-dose naltrexone
jan123: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ALT5 Sigma Corp (ALTS) | Preclinical |
Get deeper analysis on jan123
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis